Elon Musk has announced that Tesla and SpaceX will utilize Intel's latest 14A manufacturing technology for the 'Terafab' project. The announcement provided an immediate lift to Intel's shares in after-hours trading.
- Musk confirms adoption of Intel 14A tech
- Integration focused on 'Terafab' project
- Intel stock reacted positively with a 3% post-market gain
- Validates Intel's foundry turnaround strategy
- Diversifies Intel's high-end client portfolio
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.